Amneal Pharmaceuticals, Class Stock Price Prediction
| AMRX Stock | USD 8.38 0.01 0.12% |
Oversold Vs Overbought
67
Oversold | Overbought |
Quarterly Earnings Growth (0.75) | EPS Estimate Next Quarter 0.16 | EPS Estimate Current Year 0.6113 | EPS Estimate Next Year 0.7292 | Wall Street Target Price 10.5 |
Using Amneal Pharmaceuticals, hype-based prediction, you can estimate the value of Amneal Pharmaceuticals, Class from the perspective of Amneal Pharmaceuticals, response to recently generated media hype and the effects of current headlines on its competitors.
Amneal Pharmaceuticals, Hype to Price Pattern
Investor biases related to Amneal Pharmaceuticals,'s public news can be used to forecast risks associated with an investment in Amneal. The trend in average sentiment can be used to explain how an investor holding Amneal can time the market purely based on public headlines and social activities around Amneal Pharmaceuticals, Class. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Amneal Pharmaceuticals,'s market sentiment to its price can help taders to make decisions based on the overall investors consensus about Amneal Pharmaceuticals,.
The fear of missing out, i.e., FOMO, can cause potential investors in Amneal Pharmaceuticals, to buy its stock at a price that has no basis in reality. In that case, they are not buying Amneal because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amneal Pharmaceuticals, after-hype prediction price | USD 8.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Amneal |
Amneal Pharmaceuticals, After-Hype Price Prediction Density Analysis
As far as predicting the price of Amneal Pharmaceuticals, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amneal Pharmaceuticals, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Amneal Pharmaceuticals,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amneal Pharmaceuticals, Estimiated After-Hype Price Volatility
In the context of predicting Amneal Pharmaceuticals,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amneal Pharmaceuticals,'s historical news coverage. Amneal Pharmaceuticals,'s after-hype downside and upside margins for the prediction period are 6.62 and 10.16, respectively. We have considered Amneal Pharmaceuticals,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amneal Pharmaceuticals, is somewhat reliable at this time. Analysis and calculation of next after-hype price of Amneal Pharmaceuticals, is based on 3 months time horizon.
Amneal Pharmaceuticals, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Amneal Pharmaceuticals, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amneal Pharmaceuticals, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amneal Pharmaceuticals,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 1.77 | 0.00 | 0.00 | 6 Events / Month | 7 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
8.38 | 8.39 | 0.00 |
|
Amneal Pharmaceuticals, Hype Timeline
Amneal Pharmaceuticals, is presently traded for 8.38. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Amneal is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Amneal Pharmaceuticals, is about 2844.64%, with the expected price after the next announcement by competition of 8.38. About 53.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 230.5. Amneal Pharmaceuticals, recorded a loss per share of 0.86. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Amneal Pharmaceuticals, Basic Forecasting Models to cross-verify your projections.Amneal Pharmaceuticals, Related Hype Analysis
Having access to credible news sources related to Amneal Pharmaceuticals,'s direct competition is more important than ever and may enhance your ability to predict Amneal Pharmaceuticals,'s future price movements. Getting to know how Amneal Pharmaceuticals,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amneal Pharmaceuticals, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CAPR | Capricor Therapeutics | (0.08) | 11 per month | 4.10 | 0.23 | 18.22 | (7.37) | 69.31 | |
| SLNO | Soleno Therapeutics | 0.67 | 10 per month | 2.49 | 0.06 | 6.31 | (4.12) | 13.33 | |
| BPTH | Bio Path Holdings | (0.01) | 8 per month | 0.00 | (0.09) | 6.67 | (8.08) | 51.22 | |
| MBRX | Moleculin Biotech | (0.20) | 9 per month | 4.27 | 0.04 | 9.75 | (7.01) | 35.41 | |
| CRNX | Crinetics Pharmaceuticals | 1.32 | 9 per month | 2.43 | (0.01) | 3.67 | (3.45) | 16.75 | |
| ASMB | Assembly Biosciences | (0.45) | 8 per month | 4.46 | 0.01 | 8.49 | (5.34) | 24.80 | |
| TIL | Instil Bio | (1.77) | 9 per month | 6.84 | 0.12 | 20.63 | (10.89) | 105.83 | |
| CTMX | CytomX Therapeutics | (0.01) | 10 per month | 0.00 | (0.15) | 5.00 | (5.22) | 20.61 | |
| ACHL | Achilles Therapeutics PLC | (0.03) | 4 per month | 1.53 | 0.11 | 3.06 | (2.88) | 38.16 |
Amneal Pharmaceuticals, Additional Predictive Modules
Most predictive techniques to examine Amneal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amneal using various technical indicators. When you analyze Amneal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amneal Pharmaceuticals, Predictive Indicators
The successful prediction of Amneal Pharmaceuticals, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amneal Pharmaceuticals, Class, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amneal Pharmaceuticals, based on analysis of Amneal Pharmaceuticals, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amneal Pharmaceuticals,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amneal Pharmaceuticals,'s related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0957 | 0.096 | Price To Sales Ratio | 0.45 | 0.42 |
Story Coverage note for Amneal Pharmaceuticals,
The number of cover stories for Amneal Pharmaceuticals, depends on current market conditions and Amneal Pharmaceuticals,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amneal Pharmaceuticals, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amneal Pharmaceuticals,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Amneal Pharmaceuticals, Short Properties
Amneal Pharmaceuticals,'s future price predictability will typically decrease when Amneal Pharmaceuticals,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amneal Pharmaceuticals, Class often depends not only on the future outlook of the potential Amneal Pharmaceuticals,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amneal Pharmaceuticals,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 176.1 M | |
| Cash And Short Term Investments | 91.5 M |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.